These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2228838)

  • 1. Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate.
    Scaglione F; Raichi M; Fraschini F
    J Antimicrob Chemother; 1990 Sep; 26 Suppl A():1-10. PubMed ID: 2228838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.
    Regamey C
    Chemotherapy; 1985; 31(2):85-94. PubMed ID: 3987394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of cefodizime and ceftriaxone in sera and bones of patients undergoing hip arthroplasty.
    Scaglione F; De Martini G; Peretto L; Ghezzi R; Baratelli M; Arcidiacono MM; Fraschini F
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2292-4. PubMed ID: 9333066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of ceftriaxone and cefotaxime in cirrhotic patients with ascites.
    Hary L; Andrejak M; Leleu S; Orfila J; Capron JP
    Eur J Clin Pharmacol; 1989; 36(6):613-6. PubMed ID: 2776819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of pharmacokinetics of ceftriaxone in serum and pleural fluid in humans: a study of once daily administration by intramuscular and intravenous routes.
    Goonetilleke AK; Dev D; Aziz I; Hughes C; Smith MJ; Basran GS
    J Antimicrob Chemother; 1996 Dec; 38(6):969-76. PubMed ID: 9023644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of ceftriaxone in rat: application of a pharmacokinetic-protein binding model and comparison with cefotaxime.
    Hakim L; Bourne DW; Triggs EJ
    Xenobiotica; 1989 Aug; 19(8):815-22. PubMed ID: 2815824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein binding of ceftriaxone in extravascular fluids.
    McNamara PJ; Trueb V; Stoeckel K
    J Pharm Sci; 1988 May; 77(5):401-4. PubMed ID: 3411461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the influence of protein binding on serum bactericidal titres and killing rates in volunteers receiving ceftazidime, cefotaxime and ceftriaxone.
    Van der Auwera P; Klastersky J
    J Hosp Infect; 1990 Apr; 15 Suppl A():23-34. PubMed ID: 1971641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic assay of cefotaxime, desacetylcefotaxime and ceftriaxone in rat plasma.
    Hakim L; Bourne DW; Triggs EJ
    J Chromatogr; 1988 Jan; 424(1):111-7. PubMed ID: 3366822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone pharmacokinetics during iatrogenic hydroxyethyl starch-induced hypoalbuminemia: a model to explore the effects of decreased protein binding capacity on highly bound drugs.
    Mimoz O; Soreda S; Padoin C; Tod M; Petitjean O; Benhamou D
    Anesthesiology; 2000 Sep; 93(3):735-43. PubMed ID: 10969307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potencies of ceftriaxone and cefotaxime in a single chamber pharmacokinetic system simulating their in vivo half-lives.
    Unowsky J; Sattler J; Patel IH
    Chemotherapy; 1989; 35(5):338-44. PubMed ID: 2676404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
    Joly V; Pangon B; Brion N; Vallois JM; Carbon C
    J Pharmacol Exp Ther; 1988 Aug; 246(2):695-700. PubMed ID: 3042958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein binding of ceftriaxone, cefoperazone, and ceftizoxime.
    Hamilton RA; Kowalsky SF; McCormick EM; Echols RM
    Clin Pharm; 1987 Jul; 6(7):567-9. PubMed ID: 3480089
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
    Blandino G; Milazzo I; Musumeci R; Nicolosi VM; Speciale A; Nicoletti G
    J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.
    Fraschini F; Scaglione F
    Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone versus cefotaxime in the treatment of septicemia in adults.
    Ferencz A; Prinz G; Szalka A; Ban E
    Chemotherapy; 1989; 35 Suppl 2():5-9. PubMed ID: 2612239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of cefotaxime and its metabolite, desacetylcefotaxime, in rat: application of a pharmacokinetic-protein binding model.
    Hakim L; Bourne DW; Triggs EJ
    Xenobiotica; 1989 Jul; 19(7):743-54. PubMed ID: 2773510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Free concentration and protein binding of ceftriaxone].
    Saionji K; Miyake N; Miyake K; Igari J; Kobayashi I; Satoh Y
    Jpn J Antibiot; 1992 Feb; 45(2):136-42. PubMed ID: 1613966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose.
    McNamara PJ; Stoeckel K; Ziegler WH
    Eur J Clin Pharmacol; 1982; 22(1):71-5. PubMed ID: 6284519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.
    Borner K; Lode H; Hampel B; Pfeuffer M; Koeppe P
    Chemotherapy; 1985; 31(4):237-45. PubMed ID: 4028870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.